NCT07072065View on ClinicalTrials.gov

Impact Of Intralesional Tuberculin Ppd Injection On Anogenital

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

July 31, 2023

Conditions
Human Papilloma VirusInfections
Interventions
DRUG

protein purified derivative

tuberculin purified protein derivative with dose 5 tuberculin unit

Trial Locations (1)

40161

Venereology Clinic, Dr. Hasan Sadikin Hospital, Bandung

All Listed Sponsors
collaborator

National University of Malaysia

OTHER

lead

Universitas Padjadjaran

OTHER